Prof Joseph Doyle is a clinician researcher striving to eliminate threats to global health from communicable diseases with a focus on preventing and treating blood borne viruses.
Joseph is currently Professor in Infectious Diseases at Monash University, and is jointly appointed at Burnet Institute as Deputy Director of Disease Elimination Program and Head of Infectious Diseases Clinical Research. He continues to work in clinical practice as a senior infectious diseases specialist at Alfred Health. He completed his MPH at the London School of Hygiene and Tropical Medicine, his PhD at Monash School of Population Health, and hold specialist fellowships from Royal Australasian College of Physicians and Australasian Faculty of Public Health Medicine.
Joseph has experience in research leading clinical trials, cohort studies and implementation science projects to prevent and treat hepatitis C and HIV. He is a founding chief investigator of the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHECH). He has experience translating discoveries into national and global clinical guidelines as an advisor to the World Health Organisation. He has been appointed by state and national governments to statutory bodies to shape infectious diseases guidelines, regulations and treatment access, including the Pharmaceutical Benefits Advisory Committee. He is currently President-elect of the Australasian Society for Infectious Diseases.
